Biotechnology Assets S.A. Cash Flow Reinvestment Rate

Latest as of June 2025: 0.00x

Biotechnology Assets S.A. cash flow reinvestment rate. Biotechnology Assets S.A. (BST) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting €1.99K (capex €1.99K ) from operating cash flow of €658.13K. Explore Biotechnology Assets S.A. cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

€1.99K
Capex + Investments

Operating Cash Flow

€658.13K
EUR

Capital Expenditures

€1.99K
EUR

Cash Flow Reinvestment Rate of Biotechnology Assets S.A. (2015–2023)

Cash flow reinvestment rate of Biotechnology Assets S.A. from 2015 to 2023. Historical reinvestment intensity for Biotechnology Assets S.A. across 5 annual periods. Explore Biotechnology Assets S.A. capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

Biotechnology Assets S.A. Cash Flow Reinvestment Rate by Year (2015–2023)

Biotechnology Assets S.A. cash flow reinvestment rate by year from 2015 to 2023. Year-by-year capital reinvestment analysis for Biotechnology Assets S.A.. For the full cash flow conversion analysis, see Biotechnology Assets S.A. (BST) cash flow conversion.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2023 6.83x €325.97K €47.74K €325.97K ▲ +15235.3%
2020 0.04x €391.53K €8.79 Million €391.53K ▼ -99.4%
2017 7.33x €1.56 Million €213.49K €1.56 Million ▲ +508.5%
2016 1.20x €3.27 Million €2.71 Million €3.27 Million ▼ -82.2%
2015 6.75x €1.07 Million €158.16K €1.07 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow